Exhausted cytotoxic control of Epstein-Barr virus in human lupus.
about
Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causationHuman cytomegalovirus and autoimmune diseaseLupus and Epstein-BarrHerpesvirus exploitation of host immune inhibitory pathwaysCD8 T cell persistence in treated HIV infectionPD-1/CTLA-4 Blockade Inhibits Epstein-Barr Virus-Induced Lymphoma Growth in a Cord Blood Humanized-Mouse ModelEnvironmental exposures and the development of systemic lupus erythematosusSingle-cell analysis of innate cytokine responses to pattern recognition receptor stimulation in children across four continents.Evaluating cellular polyfunctionality with a novel polyfunctionality index.Reduced response to Epstein-Barr virus antigens by T-cells in systemic lupus erythematosus patients.Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosisEpstein-Barr virus encoded dUTPase containing exosomes modulate innate and adaptive immune responses in human dendritic cells and peripheral blood mononuclear cellsAntibodies to early EBV, CMV, and HHV6 antigens in systemic lupus erythematosus patientsInhibitory Receptors Beyond T Cell Exhaustion.Evasion of affinity-based selection in germinal centers by Epstein-Barr virus LMP2A.Autoimmune and Atopic Disorders and Risk of Classical Hodgkin LymphomaSerological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray.Impaired Cytokine Responses to Epstein-Barr Virus Antigens in Systemic Lupus Erythematosus PatientsEpstein-Barr virus in systemic autoimmune diseasesTherapeutic vaccination against the rhesus lymphocryptovirus EBNA-1 homologue, rhEBNA-1, elicits T cell responses to novel epitopes in rhesus macaques.Inhibitory Receptor Expression Depends More Dominantly on Differentiation and Activation than "Exhaustion" of Human CD8 T Cells.Deficient EBV-specific B- and T-cell response in patients with chronic fatigue syndrome.Epstein-Barr virus infection induces aberrant TLR activation pathway and fibroblast-myofibroblast conversion in sclerodermaAssociation of clinical and serological parameters of Systemic Lupus Erythematosus patients with Epstein-Barr virus antibody profile.T cells in Systemic Lupus Erythematosus.Correlation between Epstein-Barr Virus Infection and Disease Activity of Systemic Lupus Erythematosus: a Cross-Sectional StudyHumoral markers of active Epstein-Barr virus infection associate with anti-extractable nuclear antigen autoantibodies and plasma galectin-3 binding protein in systemic lupus erythematosus.Latent virus infection upregulates CD40 expression facilitating enhanced autoimmunity in a model of multiple sclerosis.Selective Loss of Signaling Lymphocytic Activation Molecule Family Member 4-Positive CD8+ T Cells Contributes to the Decreased Cytotoxic Cell Activity in Systemic Lupus Erythematosus.Telomere Dynamics in Immune Senescence and Exhaustion Triggered by Chronic Viral Infection.Incidence and risk of infection in egyptian patients with systemic lupus erythematosus.Strong viral associations with SLE among Filipinos.Impact of Chronic Viral Infection on T-Cell Dependent Humoral Immune Response.CTL-Promoting Effects of IL-21 Counteract Murine Lupus in the Parent→F1 Graft-versus-Host Disease Model.Positive Epstein-Barr virus detection and mortality in respiratory failure patients admitted to the intensive care unit.Immune responses to an early lytic cytomegalovirus antigen in systemic lupus erythematosus patients: T-cell responses, cytokine secretions and antibody status.[Influence of PD-1 on the immunological synapse: a facet of immune regulation ?].
P2860
Q26830464-42C08B41-CF77-467B-ACC7-3036A62CEDFBQ26850549-58605BA2-6DB1-4C2D-8C22-CD93101056DCQ26996511-3C621A4D-2ABC-4974-BAEB-0B535E4C1D95Q27013680-3A9F653C-EFAF-4937-925F-F39E88A79B42Q27014768-4666C2B5-B4AA-4C1D-BD9C-5BD780196831Q27313748-3D786AC7-C432-455A-B5A4-DBD1F3F49F8DQ28385351-C825178D-712D-453C-B126-F3C64C0A93BFQ34146281-156EE3E6-FEFB-4280-9F20-C80C78E644C7Q34364864-8FE96E4B-9FB6-4425-B179-B424C7C5A27CQ34478829-73F5874A-B820-4F3D-8900-7E5301FF25F6Q34671815-9658B381-4E81-4BD0-98A4-B62810AE9C78Q34874654-C68AFEDE-9138-4A92-8214-9E8FC48B2DD5Q35317749-702D1267-786A-4CEC-A235-3FB669183730Q35783318-94EFD2BF-4699-47ED-A199-9E458E1D11C4Q36079038-F9BE645F-5D0C-40DC-8EB8-77B8FFA6CB5EQ36089344-CA26772D-C89D-45E6-99DF-439F677857FEQ36399124-04BEF53E-0FA1-4901-88B1-BF82ACC15976Q36784009-9ACD2CAF-78ED-4603-AC99-A22E4D297D9AQ37154847-2A466DE7-429B-4D31-9CE0-722B514F0DA0Q37336847-189502C1-36F3-4ED6-8D36-FAAD9BD24973Q37402534-21D0FCF7-DA4C-477B-8BFF-9964E81D7F33Q37484088-0E1E86D3-8DEB-41C4-BFDB-E26785EB19F5Q38380369-82F32650-87B7-4FF4-BC1E-6FE25161DCDBQ38666931-9F5ED472-0B58-4AC1-8DD3-2A01BF52CD8DQ38956350-1D6A34BA-000D-4DE0-8B5F-35B1E8991A70Q40272400-F2D6A341-9B2D-4746-B0C8-2283A4B5BDAFQ40473942-0AC71907-B864-4526-A7DD-1AF49700095AQ41007071-F106ADA6-FB09-473A-ADFF-566DC1D334FBQ41029099-F94604D2-E3F0-42D9-87FF-3E6600FFDB40Q41923721-6FAE803A-05F6-4175-9E65-41BA0DB5B7C5Q42199801-E36B3493-3632-465F-B22D-E57A6282F73DQ46461196-4AF9704F-BA44-4DEF-AE10-93CE8A59E985Q47148419-EECD25A9-AEC2-4A5F-9E46-CB2523E9E5BEQ48065880-5890ED7B-CF92-4F7A-9E02-94E70E2EC943Q51565738-C68B85D3-D58E-41AB-8B42-3F099479C89BQ54263338-C2342D3A-2917-4D6C-AA9E-8728D6C6234BQ54415837-BB74FFFA-4A37-49B0-9C89-DB6444F1C5EA
P2860
Exhausted cytotoxic control of Epstein-Barr virus in human lupus.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Exhausted cytotoxic control of Epstein-Barr virus in human lupus.
@ast
Exhausted cytotoxic control of Epstein-Barr virus in human lupus.
@en
Exhausted cytotoxic control of Epstein-Barr virus in human lupus.
@nl
type
label
Exhausted cytotoxic control of Epstein-Barr virus in human lupus.
@ast
Exhausted cytotoxic control of Epstein-Barr virus in human lupus.
@en
Exhausted cytotoxic control of Epstein-Barr virus in human lupus.
@nl
prefLabel
Exhausted cytotoxic control of Epstein-Barr virus in human lupus.
@ast
Exhausted cytotoxic control of Epstein-Barr virus in human lupus.
@en
Exhausted cytotoxic control of Epstein-Barr virus in human lupus.
@nl
P2093
P2860
P1433
P1476
Exhausted cytotoxic control of Epstein-Barr virus in human lupus.
@en
P2093
Alexis Mathian
Christophe Parizot
Claire Deback
David Boutolleau
Delphine Sauce
Guy Gorochov
Karim Dorgham
Laura Papagno
Laurent Arnaud
Makoto Miyara
P2860
P304
P356
10.1371/JOURNAL.PPAT.1002328
P50
P577
2011-10-20T00:00:00Z